Status:
COMPLETED
Is Plasma Transfusion Beneficial Prior to Low-Risk Procedures in Hospitalized Patients With Blood Clotting Abnormalities?
Lead Sponsor:
Mayo Clinic
Conditions:
Blood Coagulation, Disorders
Surgical Procedures, Minimally Invasive
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
Blood clotting abnormalities or problems that happen during surgery ? even minor surgery ? are serious because of the possibility of serious bleeding that cannot be stopped. The current standard pract...
Detailed Description
While the restrictive red cell transfusion practice has become a standard of care in the acutely ill, data on the use of fresh frozen plasma (FFP) are limited. FFP transfusion may not only be poorly e...
Eligibility Criteria
Inclusion
- Inclusion:
- Consenting hospitalized adult
- (\>18 years)
- Patients with abnormal INR (INR 1.6-3) due to either vitamin K depletion or antagonism (Coumadin and/or broad spectrum antibiotics) or liver insufficiency
- Patients who are about to undergo one of the three common minimally invasive procedures (thoracocentesis, abdominal paracentesis, and central vein cannulation)
- Exclusion:
- None
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00953901
Start Date
July 1 2006
End Date
December 1 2008
Last Update
November 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905